Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 8, 2016
Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cellsA Cignarelli, S Perrini, P Nigro, et al.Journal of Clinical Pathology|October 17, 2007
Expression of periostin in human breast cancerF Puglisi, C Puppin, E Pegolo, et al.British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.Journal of Translational Medicine|June 28, 2015
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapyE Muraro, E Comaro, R Talamini, et al.ESMO Open|December 15, 2023
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysisA Rizzo, F M Schipilliti, F Di Costanzo, et al.ESMO Open|May 1, 2025
Precision oncology in biliary tract cancer: the emerging role of liquid biopsyM de Scordilli, M Bortolot, S Torresan, et al.Anticancer Research|March 26, 2002
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomasF Puglisi, G Aprile, A M Minisini, et al.ESMO Open|November 18, 2022
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic reviewV Di Lauro, G Barchiesi, F Martorana, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 4, 2008
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancerC Andreetta, C Puppin, A Minisini, et al.Breast (Edinburgh, Scotland)|June 28, 2026
What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT studyA De Luca, M I Amabile, M Tomatis, et al.Pageof 11